These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18986665)

  • 21. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses.
    Malkevitch NV; Patterson LJ; Aldrich MK; Wu Y; Venzon D; Florese RH; Kalyanaraman VS; Pal R; Lee EM; Zhao J; Cristillo A; Robert-Guroff M
    Virology; 2006 Sep; 353(1):83-98. PubMed ID: 16814356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines.
    Jones L; Ahmad S; Chan K; Verardi P; Morton WR; Grant R; Yilma T
    J Med Primatol; 2000 Aug; 29(3-4):231-9. PubMed ID: 11085585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.
    Shibata R; Siemon C; Czajak SC; Desrosiers RC; Martin MA
    J Virol; 1997 Nov; 71(11):8141-8. PubMed ID: 9343164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge.
    Patterson LJ; Robey F; Muck A; Van Remoortere K; Aldrich K; Richardson E; Alvord WG; Markham PD; Cranage M; Robert-Guroff M
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):837-49. PubMed ID: 11429125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of humoral immune responses in rhesus macaques vaccinated with attenuated SIVmac239Deltanef and challenged with pathogenic SIVmac251.
    Freissmuth D; Hiltgartner A; Stahl-Hennig C; Fuchs D; Tenner-Racz K; Racz P; Uberla K; Strasak A; Dierich MP; Stoiber H; Falkensammer B
    J Med Primatol; 2010 Apr; 39(2):97-111. PubMed ID: 20015159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
    Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge.
    Heeney JL; Holterman L; ten Haaft P; Dubbes R; Koornstra W; Teeuwsen V; Bourquin P; Norley S; Niphuis H
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S117-21. PubMed ID: 7865285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
    Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
    Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation of antigen-specific cytokine responses in the early phase of vaccination with a live-attenuated simian/human immunodeficiency chimeric virus expressing IFN-gamma.
    Iida T; Kuwata T; Ui M; Suzuki H; Miura T; Ibuki K; Takahashi H; Yamamoto T; Imanishi J; Hayami M; Kita M
    Arch Virol; 2004 Apr; 149(4):743-57. PubMed ID: 15045561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The central nervous system in mucosal vaccination of rhesus macaques with simian immunodeficiency virus Deltanef.
    Georgsson G; Stahl-Hennig C; Tenner-Racz K; Uberla K; Stoiber H; Uguccioni M; Dierich M; Ignatius R; Steinman RM; Racz P
    Neuropathol Appl Neurobiol; 2007 Dec; 33(6):644-57. PubMed ID: 17573813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
    Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus.
    Letvin NL; Li J; Halloran M; Cranage MP; Rud EW; Sodroski J
    J Virol; 1995 Jul; 69(7):4569-71. PubMed ID: 7769725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate protection against intrarectal SIV acquisition by a live SHIV vaccine.
    Sui Y; Meyer TJ; Fennessey CM; Keele BF; Dadkhah K; Ma C; LaBranche CC; Breed MW; Kramer JA; Li J; Howe SE; Ferrari G; Williams LD; Cam M; Kelly MC; Shen X; Tomaras GD; Montefiori D; Greten TF; Miller CJ; Berzofsky JA
    JCI Insight; 2024 May; 9(12):. PubMed ID: 38912579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251.
    Gómez-Román VR; Patterson LJ; Venzon D; Liewehr D; Aldrich K; Florese R; Robert-Guroff M
    J Immunol; 2005 Feb; 174(4):2185-9. PubMed ID: 15699150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation.
    Hofmann-Lehmann R; Vlasak J; Williams AL; Chenine AL; McClure HM; Anderson DC; O'Neil S; Ruprecht RM
    AIDS; 2003 Jan; 17(2):157-66. PubMed ID: 12545074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus.
    Genescà M; McChesney MB; Miller CJ
    PLoS One; 2010 Mar; 5(3):e9814. PubMed ID: 20352116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live attenuated AIDS viruses as vaccines: promise or peril?
    Ruprecht RM
    Immunol Rev; 1999 Aug; 170():135-49. PubMed ID: 10566148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus.
    Wyand MS; Manson KH; Lackner AA; Desrosiers RC
    Nat Med; 1997 Jan; 3(1):32-6. PubMed ID: 8986737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.